Geron Corporation (0IV3.L)

USD 1.3

(-12.19%)

Total Debt Summary of Geron Corporation

  • Geron Corporation's latest annual total debt in 2023 was 85.89 Million USD , up 54.07% from previous year.
  • Geron Corporation's latest quarterly total debt in 2024 Q2 was 87.04 Million USD , up 0.59% from previous quarter.
  • Geron Corporation reported annual total debt of 55.75 Million USD in 2022, up 1.37% from previous year.
  • Geron Corporation reported annual total debt of 54.99 Million USD in 2021, up 85.06% from previous year.
  • Geron Corporation reported quarterly total debt of 87.04 Million USD for 2024 Q2, up 0.59% from previous quarter.
  • Geron Corporation reported quarterly total debt of 55.84 Million USD for 2023 Q1, up 0.16% from previous quarter.

Annual Total Debt Chart of Geron Corporation (2023 - 1996)

Historical Annual Total Debt of Geron Corporation (2023 - 1996)

Year Total Debt Total Debt Growth
2023 85.89 Million USD 54.07%
2022 55.75 Million USD 1.37%
2021 54.99 Million USD 85.06%
2020 29.71 Million USD 1063.63%
2019 2.55 Million USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2016 - USD 0.0%
2015 - USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%
2011 - USD 0.0%
2010 - USD 0.0%
2009 - USD 0.0%
2008 - USD 0.0%
2007 - USD 0.0%
2006 - USD -100.0%
2005 55 Thousand USD -98.31%
2004 3.24 Million USD -47.59%
2003 6.19 Million USD -76.21%
2002 26.02 Million USD 49.39%
2001 17.41 Million USD -47.78%
2000 33.35 Million USD 82.29%
1999 18.3 Million USD 103.33%
1998 9 Million USD 291.3%
1997 2.3 Million USD -17.86%
1996 2.8 Million USD 0.0%

Peer Total Debt Comparison of Geron Corporation

Name Total Debt Total Debt Difference
uniQure N.V. 138.4 Million USD 37.938%
Agios Pharmaceuticals, Inc. 56.98 Million USD -50.732%
Amicus Therapeutics, Inc. 445.05 Million USD 80.699%
Atara Biotherapeutics, Inc. 57.87 Million USD -48.429%
bluebird bio, Inc. 330.32 Million USD 73.996%
Cara Therapeutics, Inc. 43.16 Million USD -98.992%
Imunon, Inc. 1.13 Million USD -7439.676%
Editas Medicine, Inc. 36.53 Million USD -135.108%
IQVIA Holdings Inc. 14.23 Billion USD 99.396%
Mettler-Toledo International Inc. 2.16 Billion USD 96.037%
Myriad Genetics, Inc. 145 Million USD 40.759%
Neurocrine Biosciences, Inc. 428.4 Million USD 79.949%
Supernus Pharmaceuticals, Inc. 41.52 Million USD -106.851%
Verastem, Inc. 41.55 Million USD -106.702%
Walgreens Boots Alliance, Inc. 9.55 Billion USD 99.101%
Waters Corporation 2.35 Billion USD 96.353%
Thermo Fisher Scientific Inc. 34.91 Billion USD 99.754%
Biogen Inc. 7.33 Billion USD 98.829%
Nektar Therapeutics 230.4 Million USD 62.718%
Perrigo Company plc 4.07 Billion USD 97.891%
Dynavax Technologies Corporation 256.91 Million USD 66.565%
Illumina, Inc. 2.26 Billion USD 96.203%
Corbus Pharmaceuticals Holdings, Inc. 20.88 Million USD -311.31%
Iovance Biotherapeutics, Inc. 1 Million USD -8489.9%
Heron Therapeutics, Inc. 173.75 Million USD 50.563%
Unity Biotechnology, Inc. 26.99 Million USD -218.262%
BioMarin Pharmaceutical Inc. 1.13 Billion USD 92.424%
Sangamo Therapeutics, Inc. 38.1 Million USD -125.433%
Evolus, Inc. 126.54 Million USD 32.12%
Adicet Bio, Inc. 17.7 Million USD -385.223%
Aclaris Therapeutics, Inc. 3.07 Million USD -2694.372%
Regeneron Pharmaceuticals, Inc. 2.7 Billion USD 96.822%
Esperion Therapeutics, Inc. 540.94 Million USD 84.121%
FibroGen, Inc. 170.45 Million USD 49.606%
Agilent Technologies, Inc. 2.73 Billion USD 96.859%
OPKO Health, Inc. 326.56 Million USD 73.696%
Homology Medicines, Inc. 44.05 Million USD -94.986%
Alnylam Pharmaceuticals, Inc. 2.39 Billion USD 96.418%
Exelixis, Inc. 189.94 Million USD 54.777%
Viking Therapeutics, Inc. 1.26 Million USD -6717.381%
Anavex Life Sciences Corp. - USD -Infinity%
Intellia Therapeutics, Inc. 115.34 Million USD 25.529%
Zoetis Inc. 6.8 Billion USD 98.737%
Axsome Therapeutics, Inc. 186.37 Million USD 53.91%
Abeona Therapeutics Inc. 4.4 Million USD -1851.363%
Vertex Pharmaceuticals Incorporated 808.4 Million USD 89.374%
Kala Pharmaceuticals, Inc. 36.32 Million USD -136.487%
Ionis Pharmaceuticals, Inc. 1.45 Billion USD 94.09%
Sarepta Therapeutics, Inc. 1.39 Billion USD 93.85%
Corcept Therapeutics Incorporated 151 Thousand USD -56786.755%
Halozyme Therapeutics, Inc. 1.49 Billion USD 94.271%
Blueprint Medicines Corporation 774.12 Million USD 88.904%
Insmed Incorporated 1.2 Billion USD 92.865%
TG Therapeutics, Inc. 110.79 Million USD 22.47%
Incyte Corporation 38.28 Million USD -124.356%
Emergent BioSolutions Inc. 877.5 Million USD 90.211%